Rofecoxib was a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Rofecoxib industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Oral Suspension.
Tablet-Form
Market Segment by Product Application
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Finally, the report provides detailed profile and data information analysis of leading company.
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Rofecoxib consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Rofecoxib market by identifying its various subsegments.
3.Focuses on the key global Rofecoxib manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Rofecoxib with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Rofecoxib submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Rofecoxib Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Rofecoxib Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Rofecoxib Segment by Type
2.1.1 Oral Suspension.
2.1.2 Tablet-Form
2.2 Market Analysis by Application
2.2.1 Osteoarthritis
2.2.2 Rheumatoid Arthritis
2.2.3 Juvenile Rheumatoid Arthritis
2.2.4 Acute Pain Conditions
2.2.5 Migraine
2.2.6 Dysmenorrhea
2.3 Global Rofecoxib Market Comparison by Regions (2017-2027)
2.3.1 Global Rofecoxib Market Size (2017-2027)
2.3.2 North America Rofecoxib Status and Prospect (2017-2027)
2.3.3 Europe Rofecoxib Status and Prospect (2017-2027)
2.3.4 China Rofecoxib Status and Prospect (2017-2027)
2.3.5 Japan Rofecoxib Status and Prospect (2017-2027)
2.3.6 Southeast Asia Rofecoxib Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Rofecoxib Industry Impact
2.5.1 Rofecoxib Business Impact Assessment - Covid-19
2.5.2 Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Rofecoxib Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Rofecoxib Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Rofecoxib Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Rofecoxib Manufacturer Market Share
3.5 Top 10 Rofecoxib Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Rofecoxib Market
3.7 Key Manufacturers Rofecoxib Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Rofecoxib Industry Key Manufacturers
4.1 Merck
4.1.1 Compan Detail
4.1.2 Merck Rofecoxib Product Introduction, Application and Specification
4.1.3 Merck 136 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Merck News
4.2 Chengdu Meinkai Chemical Co. LTD
4.2.1 Compan Detail
4.2.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Introduction, Application and Specification
4.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Merck News
4.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
4.3.1 Compan Detail
4.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Introduction, Application and Specification
4.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD News
4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
4.4.1 Compan Detail
4.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Introduction, Application and Specification
4.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD News
4.5 Pfizer
4.5.1 Compan Detail
4.5.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Introduction, Application and Specification
4.5.3 Pfizer Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Pfizer News
4.6 Tremeau
4.6.1 Compan Detail
4.6.2 Tremeau Rofecoxib Product Introduction, Application and Specification
4.6.3 Tremeau Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Tremeau News
5 Global Rofecoxib Market Segment by Big Type
5.1 Global Rofecoxib Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Rofecoxib Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Rofecoxib Revenue and Market Share by Big Type (2017-2022)
5.2 Oral Suspension. Sales Growth Rate and Price
5.2.1 Global Oral Suspension. Sales Growth Rate (2017-2022)
5.2.2 Global Oral Suspension. Price (2017-2022)
5.3 Tablet-Form Sales Growth Rate and Price
5.3.1 Global Tablet-Form Sales Growth Rate (2017-2022)
5.3.2 Global Tablet-Form Price (2017-2022)
6 Global Rofecoxib Market Segment by Big Application
6.1 Global Rofecoxib Sales Market Share by Big Application (2017-2022)
6.2 Osteoarthritis Sales Growth Rate (2017-2022)
6.3 Rheumatoid Arthritis Sales Growth Rate (2017-2022)
6.4 Juvenile Rheumatoid Arthritis Sales Growth Rate (2017-2022)
6.5 Acute Pain Conditions Sales Growth Rate (2017-2022)
6.6 Migraine Sales Growth Rate (2017-2022)
6.7 Dysmenorrhea Sales Growth Rate (2017-2022)
7 Global Rofecoxib Forecast
7.1 Global Rofecoxib Revenue, Sales and Growth Rate (2022-2027)
7.2 Rofecoxib Market Forecast by Regions (2022-2027)
7.2.1 North America Rofecoxib Market Forecast (2022-2027)
7.2.2 Europe Rofecoxib Market Forecast (2022-2027)
7.2.3 China Rofecoxib Market Forecast (2022-2027)
7.2.4 Japan Rofecoxib Market Forecast (2022-2027)
7.2.5 Southeast Asia Rofecoxib Market Forecast (2022-2027)
7.2.6 Other Regions Rofecoxib Market Forecast (2022-2027)
7.3 Rofecoxib Market Forecast by Type (2022-2027)
7.3.1 Global Rofecoxib Sales Forecast by Type (2022-2027)
7.3.2 Global Rofecoxib Market Share Forecast by Type (2022-2027)
7.4 Rofecoxib Market Forecast by Application (2022-2027)
7.4.1 Global Rofecoxib Sales Forecast by Application (2022-2027)
7.4.2 Global Rofecoxib Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Rofecoxib Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Rofecoxib Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Rofecoxib
Figure Market Concentration Ratio and Market Maturity Analysis of Rofecoxib
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Rofecoxib Market Size by Big Type
Figure Global Market Share of Rofecoxib by Big Type in 2021
Figure Oral Suspension. Picture (2017-2022)
Global Rofecoxib Market Size by Big Application
Table Global Rofecoxib Market Size by Application
Figure Global Rofecoxib Market Share by Big Application in 2021
Figure Osteoarthritis Picture
Figure Rheumatoid Arthritis Picture
Figure Juvenile Rheumatoid Arthritis Picture
Figure Acute Pain Conditions Picture
Figure Migraine Picture
Figure Dysmenorrhea Picture
Table Global Rofecoxib Comparison by Regions (M USD) (2017-2027)
Figure Global Rofecoxib Market Size (Million US$) (2017-2027)
Figure North America Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Figure China Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Rofecoxib Sales by Manufacturer (2017-2022)
Figure Global Rofecoxib Sales Market Share by Manufacturer in 2021
Table Global Rofecoxib Revenue by Manufacturer (2017-2022)
Figure Global Rofecoxib Revenue Market Share by Manufacturer in 2021
Table Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Rofecoxib Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Rofecoxib Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Rofecoxib Market
Table Key Manufacturers Rofecoxib Product Type
Table Mergers & Acquisitions Planning
Table Merck Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Merck
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Chengdu Meinkai Chemical Co. LTD Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Chengdu Meinkai Chemical Co. LTD
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Chengdu Meinkai Chemical Co. LTD Recent Development
Table Wuhan Xinxin Jiali Biotechnology Co. LTD Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Wuhan Xinxin Jiali Biotechnology Co. LTD
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Wuhan Xinxin Jiali Biotechnology Co. LTD Main Business
Table Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Business
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Business
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
Table Pfizer Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Pfizer
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Tremeau Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Tremeau
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Tremeau Main Business
Table Tremeau Recent Development
Figure Global Rofecoxib Sales and Growth Rate (2017-2022)
Figure Global Rofecoxib Revenue and Growth Rate (2017-2022)
Table Global Rofecoxib Sales by Regions (2017-2022)
Figure Global Rofecoxib Sales Market Share by Regions in 2021
Table Global Rofecoxib Revenue by Regions (2017-2022)
Figure Global Rofecoxib Revenue Market Share by Regions in 2021
Figure North America Rofecoxib Sales and Growth Rate (2017-2022)
Figure Europe Rofecoxib Sales and Growth Rate (2017-2022)
Figure China Rofecoxib Sales and Growth Rate (2017-2022)
Figure Japan Rofecoxib Sales and Growth Rate (2017-2022)
Figure Southeast Asia Rofecoxib Sales and Growth Rate (2017-2022)
Figure Other Regions Rofecoxib Sales and Growth Rate (2017-2022)
Table Global Rofecoxib Sales by Big Type (2017-2022)
Table Global Rofecoxib Sales Market Share by Big Type (2017-2022)
Figure Global Rofecoxib Sales Market Share by Big Type in 2019
Table Global Rofecoxib Revenue by Big Type (2017-2022)
Table Global Rofecoxib Revenue Market Share by Big Type (2017-2022)
Table Global Rofecoxib Revenue Market Share by Big Type in 2019
Figure Global Oral Suspension. Sales Growth Rate (2017-2022)
Figure Global Oral Suspension. Price (2017-2022)
Figure Global Tablet-Form Sales Growth Rate (2017-2022)
Table Global Rofecoxib Sales by Big Application (2017-2022)
Table Global Rofecoxib Sales Market Share by Big Application (2017-2022)
Figure Global Rofecoxib Sales Market Share by Big Application in 2019
Figure Global Osteoarthritis Sales Growth Rate (2017-2022)
Figure Global Rheumatoid Arthritis Sales Growth Rate (2017-2022)
Figure Global Juvenile Rheumatoid Arthritis Sales Growth Rate (2017-2022)
Figure Global Acute Pain Conditions Sales Growth Rate (2017-2022)
Figure Global Migraine Sales Growth Rate (2017-2022)
Figure Global Dysmenorrhea Sales Growth Rate (2017-2022)
Figure Global Rofecoxib Sales and Growth Rate (2022-2027)
Figure Global Rofecoxib Revenue and Growth Rate (2022-2027)
Table Global Rofecoxib Sales Forecast by Regions (2022-2027)
Table Global Rofecoxib Market Share Forecast by Regions (2022-2027)
Figure North America Sales Rofecoxib Market Forecast (2022-2027)
Figure Europe Sales Rofecoxib Market Forecast (2022-2027)
Figure China Sales Rofecoxib Market Forecast (2022-2027)
Figure Japan Sales Rofecoxib Market Forecast (2022-2027)
Figure Southeast Asia Sales Rofecoxib Market Forecast (2022-2027)
Figure Other Regions Sales Rofecoxib Market Forecast (2022-2027)
Table Global Rofecoxib Sales Forecast by Type (2022-2027)
Table Global Rofecoxib Market Share Forecast by Type (2022-2027)
Table Global Rofecoxib Sales Forecast by Application (2022-2027)
Table Global Rofecoxib Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rofecoxib
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Rofecoxib Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Rofecoxib Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Rofecoxib Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Rofecoxib Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Rofecoxib Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Rofecoxib Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Rofecoxib Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Rofecoxib Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)